The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

The use of weight-loss injections has become near-normalised in today's society, but one singer is joining the charge in warning against their side effects, after she claims Ozempic has left her with ...

Crypto is in a cooling period after running to a new record last week and was pulled lower by the DeepSeek-driven sell-off in tech stocks.

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Huge crowds have come out to Chinatown for Lunar New Year as new political faces take office. She made the look her own with ...

The beef between the two hip-hop stars seemed to reach a point of no return after Lamar released his diss track "Not Like Us.

Michael Batnick said the outperformance of consumer discretionary stocks relative to consumer staples is "the most bullish ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...

It comes after Michelle revealed the truth behind her incredible nine-stone weight loss and insisted "it wasn't Ozempic". The Pop Idol winner opened up about her weight loss journey on Good ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

Novo Nordisk’s semaglutide products Ozempic, Wegovy and Rybelsus are leading the GLP-1 boom and fueling a hot obesity market, but they’re also at the top of CMS’ target list based on ...